|1.||Zhong, Nanshan: 3 articles (11/2015 - 10/2009)|
|2.||Wu, Yizhuang: 2 articles (08/2013 - 10/2009)|
|3.||Liang, Chenyuan: 1 article (11/2015)|
|4.||Liu, Zhe: 1 article (11/2015)|
|5.||Xia, Hui: 1 article (11/2015)|
|6.||Li, Longjiang: 1 article (11/2015)|
|7.||Zhang, Zhuoyuan: 1 article (11/2015)|
|8.||Pan, Jian: 1 article (11/2015)|
|9.||Xu, Xiaoming: 1 article (08/2013)|
|10.||Zhang, Chenting: 1 article (08/2013)|
08/01/2013 - "Para-toluenesulfonamide (PTS), a unique antitumor drug for local intratumoral injection, shows an efficacy of severely suppressing solid tumor growth with mild side effects in clinical trials. "
11/01/2015 - "Para-toluenesulfonamide (PTS) has been implicated with anticancer effects against a variety of tumors. "
12/14/2012 - "As a unique antitumor agent in form of lipophilic fluid for local injection, para-toluenesulfonamide (PTS) produces mild side effects while necrotizing the tumor tissues quickly and efficiently. "
|2.||Lung Neoplasms (Lung Cancer)
08/01/2013 - "Antitumor effect of para-toluenesulfonamide against lung cancer xenograft in a mouse model."
10/01/2009 - "Gemcitabine plus cisplatin chemotherapy with concurrent para-toluenesulfonamide local injection therapy for peripherally advanced nonsmall cell lung cancer larger than 3 cm in the greatest dimension."
|3.||Hepatocellular Carcinoma (Hepatoma)
12/14/2012 - "Puncture injection of para-toluenesulfonamide combined with chemoembolization for advanced hepatocellular carcinoma."
02/01/2008 - "To investigate the dose-effect relationship of para-toluenesulfonamide (PTS) for treatment of hepatocellular carcinoma in rats. "
02/01/2008 - "[Dose-effect relationship of para-toluenesulfonamide for treatment of hepatocellular carcinoma in rats]."
|4.||Squamous Cell Carcinoma (Epidermoid Carcinoma)
|1.||Heterologous Transplantation (Xenotransplantation)
|2.||Drug Therapy (Chemotherapy)